COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,927 Articles (22,054 medRxiv, 7,873 bioRxiv)

Most recent first Previous |  Page 2829: Articles 28281-28290  | Next

The first month of the COVID-19 outbreak in 46 sub-Saharan African countries; a comparative analysis of growth rates
Prince, M. J., Alem, A., Chibanda, D., Fairall, L., Fekadu, A., Hanlon, C., Lund, C., Leather, A. J., Petersen, I., Verhey, R., Wurie, H.
10.1101/2020.04.09.20057091 — Posted: 2020-04-14
Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
Gonzalez, J. M., Shelton, J. W., Diaz-Vallejo, M., Rodriguez-Castellanos, V. E., Zuluaga, J. D. H., Chamorro, D. F., Arroyo-Ariza, D.
10.1101/2020.04.10.20061150 — Posted: 2020-04-14
Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review
Lem, F. F., Opook, F., Herng, D. L. J., Na, C. S., Lawson, F. P., Tyng, C. F.
10.1101/2020.04.10.20060376 — Posted: 2020-04-14
A SIMPLE COLORIMETRIC MOLECULAR DETECTION OF NOVEL CORONAVIRUS (COVID-19), AN ESSENTIAL DIAGNOSTIC TOOL FOR PANDEMIC SCREENING
ANNAMALAI, P., KANTA, M., RAMU, P., RAVI, B., VEERAPANDIAN, K., SRINIVASAN, R.
10.1101/2020.04.10.20060293 — Posted: 2020-04-14
Multi-Stage Group Testing Optimizes COVID-19 Mass Population Testing
Eberhardt, J. N., Breuckmann, N. P., Eberhardt, C. S.
10.1101/2020.04.10.20061176 — Posted: 2020-04-14
Clinical features and management of severe COVID-19: A retrospective study in Wuxi, Jiangsu Province, China
Jiang, X., Tao, J., Wu, H., Wang, Y., Zhao, W., Zhou, M., Huang, J., You, Q., Meng, H., Zhu, F., Zhang, X., Qian, M., Qiu, Y.
10.1101/2020.04.10.20060335 — Posted: 2020-04-14
COVID-19 Global Pandemic Planning: Decontamination and Reuse Processes for N95 Respirators
Perkins, D. J., Villescas, S., Wu, T. H., Muller, T. B., Bradfute, S., Foo-Hurwitz, I., Cheng, Q., Wilcox, H., Weiss, M., Bartlett, C., Langsjoen, J., Seidenberg, P.
10.1101/2020.04.09.20060129 — Posted: 2020-04-14
Chasing the ghost of infection past: identifying thresholds of change during the COVID-19 infection in Spain
Santamaria, L., Hortal, J.
10.1101/2020.04.09.20059345 — Posted: 2020-04-14
Analysing recovery from pandemics by Learning Theory: the case of CoVid-19
Duffey, R. B., Zio, E.
10.1101/2020.04.10.20060319 — Posted: 2020-04-14
Estimating required lockdown cycles before immunity to SARS-CoV-2: Model-based analyses of susceptible population sizes, S0, in seven European countries including the UK and Ireland
Moran, R. J., Fagerholm, E. D., Daunizeau, J., Cullen, M., Richardson, M. P., Williams, S., Turkheimer, F., Leech, R., Friston, K.
10.1101/2020.04.10.20060426 — Posted: 2020-04-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).